肥胖的两种并发症:非酒精性脂肪性肝炎与肝细胞癌
非酒精性脂肪性肝炎(NASH)是发达国家慢性肝病最常见病因,发病率快速上升,肝硬化和肝细胞癌(HCC)是NASH发病和死亡的主要驱动因素。传统认为慢性肝损伤导致细胞死亡、再生和纤维化循环,HCC前体细胞恶性转化引发癌症,流行病学数据显示在丙型肝炎和酒精性肝硬化等多种慢性肝病中,超过90%的患者HCC前有肝硬化。但NASH患者中纤维化与癌变的联系似乎不那么明确,相当比例NASH相关HCC患者没有显著的基础纤维化。若干病例报告和病例系列指出了非肝硬化NASH发生HCC的现象,一项纳入19项研究的近期Meta分析显示,非肝硬化NASH中HCC的患病率高达38.0%。肥胖在无NASH和/或明显纤维化或肝硬化情况下促进HCC发生的机制仍未被探索,近期《Cell》的一篇论文报道了一种可能解释肥胖独立于NASH在HCC发病中作用的机制。
要点
- NASH是发达国家慢性肝病最常见病因,肝硬化和HCC是NASH发病和死亡的主要驱动因素。
- 流行病学数据显示,在丙型肝炎和酒精性肝硬化等多种慢性肝病中,超过90%的患者HCC前有肝硬化。
- 一项纳入19项研究的Meta分析显示,非肝硬化NASH中HCC的患病率高达38.0%。
核心结论
- NASH患者中纤维化与癌变的联系似乎不那么明确,相当比例NASH相关HCC患者没有显著的基础纤维化。
- 肥胖在无NASH和/或明显纤维化或肝硬化情况下促进HCC发生的机制仍未被探索,近期《Cell》的一篇论文报道了一种可能解释肥胖独立于NASH在HCC发病中作用的机制。
研究设计与样本
- 本文为综述,引用若干病例报告和病例系列指出非肝硬化NASH发生HCC的现象,并引用一项纳入19项研究的Meta分析数据。
主要发现
- 传统认为慢性肝损伤导致细胞死亡、再生和纤维化循环,HCC前体细胞恶性转化引发癌症。
- 流行病学数据显示,在丙型肝炎和酒精性肝硬化等多种慢性肝病中,超过90%的患者HCC前有肝硬化。
- 一项纳入19项研究的Meta分析显示,非肝硬化NASH中HCC的患病率高达38.0%。
关键数值与推荐
- 在丙型肝炎和酒精性肝硬化等多种慢性肝病中,超过90%的患者HCC前有肝硬化。
- 一项纳入19项研究的Meta分析显示,非肝硬化NASH中HCC的患病率高达38.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in developed countries and its incidence is rapidly increasing. Cirrhosis, and the dreaded complication of hepatocellular carcinoma (HCC), are the major drivers of morbidity and mortality in NASH. Conventional understanding has been that chronic liver damage leads to a cycle of cell death, regeneration and fibrosis during which HCC precursor cells undergo malignant transformation and lead to cancer initiation. This is supported by epidemiologic data which shows that cirrhosis precedes HCC in more than 90% of patients with several forms of chronic liver disease like hepatitis C and alcohol cirrhosis. But the link between fibrosis and carcinogenesis seems less definitive in patients with NASH as a sizeable proportion of NASH patients with HCC do not have significant underlying fibrosis. Several case reports and case series have pointed out this phenomenon of HCC arising in non-cirrhotic NASH (1), and a recent meta-analysis of 19 studies has shown that the prevalence of HCC in non-cirrhotic NASH was up to 38.0% (2). The mechanisms that contribute to the development of HCC in obesity in the absence of NASH and/or overt fibrosis or cirrhosis have remained unexplored. A possible mechanism to explain the role of obesity in the pathogenesis of HCC independent of NASH, was recently reported in a paper in Cell (3) . [Image: see text]
引用
- Dhanasekaran R, Felsher DW. A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30958566. doi:10.1002/hep.30649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。